Needle exchange pg 25

• Individuals attending needle exchange
• (Quarterly in arrears)
• 1,440 inQ1 2016, 1,669 in Q4 2015 (Target 1,731)
• Below target: CHO1 21 (Target 58), CHO2 115 (Target 129), CHO3 266 (Target 314) CHO4 308 (Target 393)CHO5 334 (Target 372) CHO8 396 (Target 465)

 Data returned tri monthly, quarterly in arrears

Opioid Substitute Treatment (month in arrears) pg 26

• 9,608 patients received treatment (excluding prisons) as of the end of May which includes 4,098 patients being treated by 353 GPs in the community.
• 663 pharmacies dispensed treatment catering for 6,633 patients.
• 77 HSE clinics were providing treatment and an additional 10 prison clinics were provided in the prison service.
• 71 new patients commenced treatment during May (11 in General Practice, 40in HSE clinics and 20 in the prison clinics).
• The majority of Opioid Substitution Treatment (OST) KPIs are on target with the exception of transfers. Reasons behind the below target transfer of stabilised clients to the lowest level of complexity (Level 1) from clinics and Level 2 GPs is being examined via Performance Meetings.